Skip to content Skip to navigation

Mounjaro gets FDA approval to lower heart attack, stroke risk in diabetes patients

August 31, 2026 at 08:40 EDTWNEP

Tags:

The FDA approved Mounjaro to reduce the risk of heart attack, stroke and cardiovascular death in certain adults with type 2 diabetes.